These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31273695)

  • 21. Pharmacologic control of pemoline induced self-injurious behavior in rats.
    Mueller K; Nyhan WL
    Pharmacol Biochem Behav; 1982 Jun; 16(6):957-63. PubMed ID: 6213967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemoline hepatotoxicity in children.
    Marotta PJ; Roberts EA
    J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pemoline-associated hepatic failure: a critical analysis of the literature.
    Shevell M; Schreiber R
    Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reaction. Pemoline and dyskinesia.
    Shuster J
    Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
    [No Abstract]   [Full Text] [Related]  

  • 25. Delusional parasitosis associated with pemoline.
    Krauseneck T; Soyka M
    Psychopathology; 2005; 38(2):103-4. PubMed ID: 15855835
    [No Abstract]   [Full Text] [Related]  

  • 26. Pemoline in ADHD.
    Winsberg B; Barbato M
    J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychostimulants in supportive care.
    Homsi J; Walsh D; Nelson KA
    Support Care Cancer; 2000 Sep; 8(5):385-97. PubMed ID: 10975688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical use of psychostimulants: an overview.
    Holmes VF
    Int J Psychiatry Med; 1995; 25(1):1-19. PubMed ID: 7649714
    [No Abstract]   [Full Text] [Related]  

  • 29. Pemoline therapy resulting in liver transplantation.
    Adcock KG; MacElroy DE; Wolford ET; Farrington EA
    Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuropathology of Self-Injurious Behavior: Studies using animal models.
    Devine DP
    Brain Res; 2024 Dec; 1844():149172. PubMed ID: 39163896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated pemoline produces self-injurious behavior in adult and weanling rats.
    Mueller K; Hollingsworth E; Pettit H
    Pharmacol Biochem Behav; 1986 Nov; 25(5):933-8. PubMed ID: 3786367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-injurious behaviour in autistic children: a neuro-developmental theory of social and environmental isolation.
    Devine DP
    Psychopharmacology (Berl); 2014 Mar; 231(6):979-97. PubMed ID: 24057764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exacerbation of autoimmune hepatitis: another hepatotoxic effect of pemoline therapy.
    Hochman JA; Woodard SA; Cohen MB
    Pediatrics; 1998 Jan; 101(1 Pt 1):106-8. PubMed ID: 9417161
    [No Abstract]   [Full Text] [Related]  

  • 34. Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.
    Rosh JR; Dellert SF; Narkewicz M; Birnbaum A; Whitington G
    Pediatrics; 1998 May; 101(5):921-3. PubMed ID: 9565425
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative analysis of self-injury in people with psychopathology or neurodevelopmental disorders.
    Crapper L; Ernst C
    Pediatr Clin North Am; 2015 Jun; 62(3):619-31. PubMed ID: 26022166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reduction of dysfunctional self-injurious and self-stimulatory behaviors in autism disorders spectrum through occupational therapy].
    Tudela Torras M; Abad Más L
    Medicina (B Aires); 2019; 79(Suppl 1):38-43. PubMed ID: 30776278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inappropriate pemoline therapy leading to acute liver failure and liver transplantation.
    Abbiati C; Vecchi M; Rossi G; Donata MF; de Franchis R
    Dig Liver Dis; 2002 Jun; 34(6):447-51. PubMed ID: 12132793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pemoline-induced self-biting in rats and self-mutilation in the deLange syndrome.
    Mueller K; Hsiao S
    Pharmacol Biochem Behav; 1980 Nov; 13(5):627-31. PubMed ID: 7192403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.